These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 661768)

  • 1. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
    Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary experience with the treatment of a case of Wiskott-Aldrich syndrome with transfer factor].
    Balsamo V; Brai M; Mogavero S; Tolone G; La Grutta A
    Minerva Pediatr; 1977 Mar; 29(10):651-5. PubMed ID: 875932
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo enhancement of mixed lymphocyte culture reactivity by thymosin in patients with primary immunodeficiency disease.
    Wara DW; Barrett DJ; Ammann AJ; Cowan MJ
    Ann N Y Acad Sci; 1979; 332():128-34. PubMed ID: 161150
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer factor therapy: evidence for nonspecificity.
    Ballow M; Dupont B; Hansen JA; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):457-61. PubMed ID: 125119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal immune responses in the ocular presentation of Wiskott-Aldrich syndrome.
    Guss RB; McCulley JP
    Ann Ophthalmol; 1982 Nov; 14(11):1058-60. PubMed ID: 7181336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wiskott-Aldrich syndrome with 18-year survival. Treatment with transfer factor.
    Sellars WA; South MA
    Am J Dis Child; 1975 May; 129(5):622-7. PubMed ID: 806224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer factor therapy in immunodeficiency.
    Griscelli C
    Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
    [No Abstract]   [Full Text] [Related]  

  • 9. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome].
    Schütt C; Eggers G; Schröder I; Kruse H; Schulz M; Blau HJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):677-84. PubMed ID: 6198251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of Wiscott-Aldrich syndrome with transfer factor].
    Endre L; Nékám K; Osváth P; Nagy M; Károly U; Uhl K
    Orv Hetil; 1979 Sep; 120(39):2361-6. PubMed ID: 392396
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephropathy in the Wiskott-Aldrich syndrome.
    Spitler LE; Wray BB; Mogerman S; Miller JJ; O'Reilly RJ; Lagios M
    Pediatrics; 1980 Sep; 66(3):391-8. PubMed ID: 7422429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe combined immunodeficiency with cartilage-hair hypoplasa: in vitro response to thymosin and attempted reconstitution.
    Steele RW; Britton HA; Anderson CT; Kniker WT
    Pediatr Res; 1976 Dec; 10(12):1003-5. PubMed ID: 995498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transfer factor. Immunologic basis and therapeutic experience].
    Hitzig WH; Fontanellaz HP; Müntener U; Paul S; Spitler LE; Fudenberg HH
    Schweiz Med Wochenschr; 1972 Sep; 102(35):1237-44. PubMed ID: 5054632
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody deficiency syndromes.
    James DG
    Trans Med Soc Lond; 1970; 86():130-7. PubMed ID: 5494691
    [No Abstract]   [Full Text] [Related]  

  • 17. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
    Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
    J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy today. II. Immunostimulating therapy].
    D'Amelio R
    Riv Med Aeronaut Spaz; 1978; 41(1):75-114. PubMed ID: 93770
    [No Abstract]   [Full Text] [Related]  

  • 19. Thymic function in man.
    Pahwa R; Ikehara S; Pahwa SG; Good RA
    Thymus; 1979 Sep; 1(1-2):27-58. PubMed ID: 317931
    [No Abstract]   [Full Text] [Related]  

  • 20. [Some immunohematological aspects of 2 cases of the Wiskott-Aldrich syndrome].
    Ferrara M; Ponte G; Esposito L
    Pediatria (Napoli); 1983; 91(1):75-80. PubMed ID: 6604260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.